Author:
NIERENBERG ANDREW A.,FEIGHNER JOHN P.,RUDOLPH RICHARD,COLE JONATHAN O.,SULLIVAN JOANNE
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Psychiatry and Mental health
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study’s patient-level data with fidelity to the original research protocol;BMJ Open;2023-07
2. Does the Presence of Dissociative Symptoms Affect the Response to Venlafaxine Treatment for Major Depression? An Open-Label, Prospective Study;Psychiatric Annals;2022-03
3. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine, Desvenlafaxine, Duloxetine, Milnacipran, Levomilnacipran;NeuroPsychopharmacotherapy;2022
4. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Venlafaxine, Desvenlafaxine, Duloxetine, Milnacipran, Levomilnacipran;NeuroPsychopharmacotherapy;2022
5. Depression and Anxiety Disorders;The Maudsley Prescribing Guidelines in Psychiatry;2021-12-17